The Washington Post reports on a meeting between President-elect Trump, Robert F. Kennedy, Jr. and a number of CEOs of pharmaceutical firms.
When the topic turned to vaccines, the discussion was not about banning the products, the three people said. Kennedy spoke about the need for better study of the vaccine dosing schedule for newborns and the rise in chronic disease, while also rattling off statistics about the increase in autism rates despite multiple studies that have shown no link between vaccines and the disorder and World Health Organization estimates that immunizations have saved 154 million lives, according to two of the people.
Here Trump redirected the conversation again, while backing up Kennedy’s desire for more research, two people said. He suggested to the drug company executives that they had nothing to fear from further investigation of the causes of autism, saying Kennedy could help put to rest vaccine hesitancy if no connection was found.
You can read the full article about the alleged meeting here.
Leave a comment